116 filings
Page 5 of 6
8-K
0c8lcplof8v
24 Jan 22
TScan Therapeutics Announces FDA Clearance of Investigational New Drug
7:31am
8-K
l5hmpm5mcs75
2 Dec 21
Entry into a Material Definitive Agreement
7:31am
8-K
9upe0
10 Nov 21
TScan Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress
7:02am
10-Q
75s 2edm1asb5d
19 Aug 21
Quarterly report
7:31am
8-K
43f1d85artz
19 Aug 21
TScan Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress
7:15am
8-K
mf85idf97y76xz4c9jet
20 Jul 21
Departure of Directors or Certain Officers
4:36pm
424B4
4vhrt6134qpuu k7qm
19 Jul 21
Prospectus supplement with pricing info
7:01am
S-8
ecf0m9gsm
16 Jul 21
Registration of securities for employees
7:01am
EFFECT
vh0gih6rldpt69o
16 Jul 21
Notice of effectiveness
12:15am
FWP
df88gph
16 Jul 21
Free writing prospectus
12:00am
S-1MEF
ehw94 z8lw
15 Jul 21
Registration of additional securities for an S-1
9:38pm
CERT
wax9m
15 Jul 21
Certification of approval for exchange listing
10:40am
SEC STAFF
219 77pg6
15 Jul 21
SEC staff action: Order
12:00am
CORRESP
tqffrv 4zk5ovaz
14 Jul 21
Correspondence with SEC
12:00am
8-A12B
izs4hmgkzkl1d623wm
13 Jul 21
Registration of securities on exchange
4:05pm
UPLOAD
agmes4tw
13 Jul 21
Letter from SEC
12:00am
CORRESP
eyvr6cv9un943c
13 Jul 21
Correspondence with SEC
12:00am
CORRESP
m4y 7jgltq0
13 Jul 21
Correspondence with SEC
12:00am